ZYLOX-TONBRDG.MED.TECH.H1 (F:818) — Stock Price
ZYLOX-TONBRDG.MED.TECH.H1 (F:818) is currently trading at €1.88 EUR, down 4.08% today. Over the past 52 weeks, shares have ranged between €1.88 and €2.98. This page tracks ZYLOX-TONBRDG.MED.TECH.H1's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of ZYLOX-TONBRDG.MED.TECH.H1.
ZYLOX-TONBRDG.MED.TECH.H1 (818) Stock Price Chart — Daily History & Trading Volume
The chart below tracks ZYLOX-TONBRDG.MED.TECH.H1's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
ZYLOX-TONBRDG.MED.TECH.H1 Income Statement — Revenue, Profit & Earnings by Year
ZYLOX-TONBRDG.MED.TECH.H1's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue | €782.48 Million | €527.75 Million | €334.09 Million | €177.91 Million |
| Cost of Revenue | €222.58 Million | €142.77 Million | €81.42 Million | €46.03 Million |
| Gross Profit | €559.89 Million | €384.99 Million | €252.67 Million | €131.88 Million |
| Research & Development | €233.22 Million | €261.01 Million | €233.46 Million | €168.10 Million |
| SG&A | €265.75 Million | €277.92 Million | €249.47 Million | €195.87 Million |
| Total Operating Expenses | €705.41 Million | €671.85 Million | €556.28 Million | €396.25 Million |
| Operating Income | €77.07 Million | €-144.09 Million | €-222.19 Million | €-218.33 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €2.17 Million | €1.25 Million | €722.00K | €307.00K |
| Income Before Tax | €100.26 Million | €-78.73 Million | €-113.56 Million | €-199.69 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €100.26 Million | €-78.73 Million | €-113.56 Million | €-199.69 Million |
ZYLOX-TONBRDG.MED.TECH.H1 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes ZYLOX-TONBRDG.MED.TECH.H1's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | €3.45 Billion | €3.38 Billion | €3.25 Billion | €3.25 Billion |
| Total Current Assets | €1.53 Billion | €1.72 Billion | €2.06 Billion | €3.02 Billion |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | €864.78 Million | €424.29 Million | €655.37 Million | €1.51 Billion |
| Net Receivables | €1.54 Million | €1.18 Million | €1.01 Million | €446.00K |
| Inventory | €205.48 Million | €166.54 Million | €119.24 Million | €57.27 Million |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | — | — | — | — |
| Total Liabilities | €351.56 Million | €328.32 Million | €159.54 Million | €103.61 Million |
| Total Current Liabilities | €334.17 Million | €317.78 Million | €152.08 Million | €97.10 Million |
| Long-term Debt | — | — | — | €0.00 |
| Net Debt | — | — | — | — |
| Total Stockholder Equity | €3.10 Billion | €3.05 Billion | €3.09 Billion | €3.14 Billion |
| Retained Earnings | €65.28 Million | €-481.91 Million | €-403.17 Million | €-289.62 Million |
ZYLOX-TONBRDG.MED.TECH.H1 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how ZYLOX-TONBRDG.MED.TECH.H1 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | €174.08 Million | €98.44 Million | €-91.32 Million | €-116.21 Million |
| Capital Expenditures | €191.34 Million | €190.92 Million | €145.28 Million | €89.59 Million |
| Free Cash Flow | €-17.26 Million | €-92.48 Million | €-236.60 Million | €-205.80 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | — | — | — | — |
| Stock-Based Compensation | €23.74 Million | €85.77 Million | €87.68 Million | €76.21 Million |
| Depreciation | €37.85 Million | €35.88 Million | €26.27 Million | €13.38 Million |
| Change in Cash | €-669.26 Million | €-119.26 Million | €-216.62 Million | €1.37 Billion |
ZYLOX-TONBRDG.MED.TECH.H1 Earnings History — EPS Actual vs. Analyst Estimates
Track ZYLOX-TONBRDG.MED.TECH.H1's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for ZYLOX-TONBRDG.MED.TECH.H1.